Radical resection for recurrent cholangiocellular carcinoma (CCC) is rare, with three metachronous radical resections reported to date in only two patients. Both patients underwent major hepatectomy twice after pancreatoduodenectomy (PD) for metachronous CCC (1). The recurrence rate after radical resection (R0) of intrahepatic cholangiocellular carcinoma (IHCC) is 50%-80%, with the rate of second resection being only 11% (2). Liver metastasis after initial resection of lower bile duct cancer has been reported in 9%-45% of patients, with the rate of second resection, including hepatectomy, being only 10% (3). Furthermore, only 2.1% of patients undergo complete radical hepatectomy for liver metastasis after PD (4). This report describes a patient who underwent repeated resections with curative intent of CCC after PD for cancer of the middle bile duct.
Pathological examination of the resected specimen revealed a well-differentiated CCC, considered the third primary tumor (intraductal growth type, s0, vp0, vv0, va0, im(-) sm(-), T2 N0 M0 fStage II ; Fig. 8 ). Despite our strong recommendation, the patient refused adjuvant therapy. He survived without metastasis or recurrence after the operation, however, 28 months after surgery, lung metastases were found and partial lung resection was performed. Histological examination of the specimen showed the same features, indicating a further metastasis of the previous hilar bile duct cancer.
DISCUSSION
Duplicated cancers has been defined as malignant tumors occupying sites distant from each other, with one not derived from the other tumor (5) . In addition, duplicated cancers generally occur within one year (3). In our patient, the histological types of the three tumors differed, they occurred in different locations, and the times between occurrence were longer than one year each. Thus, these tumors can be diagnosed as metachronous triple biliary cancer.
Tumors that recur after resection of biliary tract cancers are often unresectable ; these include multiple organ and distant lymph node metastases, as well as perivascular nerve plexus invasion. Recurrences are considered resectable when localized, but the effects of aggressive resection of CCC recurrence remain unclear. Repeated radical resections for metachronous biliary tract cancers after hepatectomy are extremely rare. To date, simultaneous occurrence of metachronial triple biliary cancer has been reported in only one patient (6), whereas metachronous occurrence has not been observed. Furthermore, to our knowledge, only two patients have undergone two or more liver resections after PD (1, 7) . Liver resection for recurrent biliary tract cancer has been reported to significantly improve patient prognosis (14 -16). One study described surgical resection for recurrent biliary tract cancer in 74 (12.2%) of 606 patients, including three patients who underwent PD for local recurrence, 24 who underwent hepatic resection for liver metastasis, and 23 who underwent resection for chest or abdominal wall metastasis (8) . The three -year overall survival rate was significantly higher in patients who did than did not undergo surgical resection (32.0% vs 3.0% ; P !0.001). Furthermore, surgical resection for recurrent CCC was an independent prognostic factor for overall survival after recurrence (8) . Although resection is the most effective treatment, if possible, chemotherapeutic agents, including gemcitabine, cisplatin, and tegafur-gimeracil-oteracil potassium (TS-1), have been shown successful results in patients with unresectable recurrent biliary tract cancers (9 -12) . The combination of resection and chemotherapy may be a powerful option in the treatment of patients with recurrent tumors. For example, neoadjuvant or adjuvant GFP (gemcitabine, low dose cisplatin, and 5 -fluorouracil) has been shown effective in patients with bile duct cancer (13). Our treatment algorithm for patients with bile duct cancers therefore consists of R0 surgical resection after GFP treatment, whether the tumor is curable or not.
In this time, we did not undergo the caudate lobectomy. For perihilar cholangiocarcinoma, the major lobectomy with the caudate lobectomy is generally planned (19) , however, there were some reports that caudate lobectomy was not related to the Fig. 2 Abdominal dynamic CT of our patient ; (a) early phase (b) portal phase (c) and late phase. The edges of the tumor were enhanced during early phase, whereas the internal area was slightly enhanced during portal and late phases. The Journal of Medical Investigation Vol. 64 August 2017 prognosis considering the remnant liver volume, cancer margin of the bile duct and operative invasiveness (20, 21) . In this case, we judged that caudate lobectomy was not suitable when we evaluated the patient's intraoperative findings and preoperative liver function volume.
Repeated radical resection for CCC is extremely rare. There are some reasons that make the repeated surgery difficult, one of which would be the tumor factors such as location, the number of tumor and the size, especially the anatomical changes resulting from the intensive procedure performed at the previous resection. In metachronous of biliary tract cancer, the clear evidence was not demonstrated so far. There are some reports which insisted the advantages of the resection by showing the long-term survival after repeated operation (17, 18) . Aggressive resection is therefore an option for patients with repeated CCC.
CONCLUSIONS
In conclusion, we have experienced the long-term survival case repeated radical resections for metachronous biliary tract cancers after hepatectomy. Aggressive resection is an option for patients with recurrent CCC.
CONSENT
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
ABBREVIATIONS
AFP : α-fetoprotein AMY : amylase (Fig. 4) . 
